Practices to decrease rate of hospital acquired infection in babies admitted in NIC
Phase 1
Completed
- Conditions
- Health Condition 1: P369- Bacterial sepsis of newborn, unspecified
- Registration Number
- CTRI/2019/03/018240
- Lead Sponsor
- eslie lewis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 66
Inclusion Criteria
All Babies admitted in NICU for more than 3 days of life.
Exclusion Criteria
• Babies with positive blood culture within 3 days of admission.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence of blood culture positive hospital acquired infection after 6 monthsTimepoint: 6 months
- Secondary Outcome Measures
Name Time Method incidence of blood culture positive hospital acquired infection after every monthTimepoint: 1 month
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie bacterial sepsis in newborns with hospital acquired infections?
How effective are quality initiatives compared to standard-of-care in reducing NICU bloodstream infections?
Are there specific biomarkers that identify neonates at high risk for P369 bacterial sepsis following NICU admission?
What adverse events are associated with NICU infection prevention protocols and how are they managed?
What combination therapies or alternative strategies show promise in combating neonatal hospital acquired sepsis?